Changes in Product Use and Quality of Life After Patch Testing in Children With Allergic Contact Dermatitis: A Follow-up Survey

被引:1
|
作者
Pollard, Bruin [1 ]
Collis, Reid W. [1 ]
Stahl, Dylan [1 ,2 ]
Coughlin, Carrie C. [3 ,4 ]
Sheinbein, David M. [3 ]
机构
[1] Washington Univ, Sch Med, Med Educ Program, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Med, Div Dermatol, 660 S Euclid Ave, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave, St Louis, MO 63110 USA
关键词
D O I
10.1097/DER.0000000000000796
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Patch testing is the standard to diagnose allergic contact dermatitis (ACD). Objective This study assessed the value of patch testing for product changes and quality of life in children with ACD. Methods In this cross-sectional survey, we used a questionnaire to follow up with families of ACD patients about changes since patch testing and counseling preferences. Eligible participants were 18 years or younger during expanded series or personalized patch tests at the Washington University School of Medicine from 2007 to 2020. Results Of the 43 enrolled participants, most were positive for multiple allergens (63%) and changed personal products after patch testing (71%). Only 26% of the families consistently read product labels before patch testing, compared with 66% after. Patients saw a mean relative reduction of 49% in severity of rash (8.2-4.2 of 10), 46% in interference with activities (5.7-3.1), and 51% in self-consciousness (7.0-3.4) since patch testing. Families gave favorable feedback for counseling on products to avoid (9.4 of 10 average rating of usefulness), product recommendations (8.5 of 10), and chemical names (7.9 of 10). Conclusions Patch testing can lead to meaningful improvements in quality of life for most children with ACD. Counseling related to positive patch test results should include discussion of specific products to use and avoid.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [21] The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitis
    Rajagopalan, R
    Anderson, RT
    Sarma, S
    Retchin, C
    Jones, J
    PHARMACOECONOMICS, 1998, 14 (01) : 79 - 95
  • [22] The Use of Decision-Analytical Modelling in Economic Evaluation of Patch Testing in Allergic Contact Dermatitis
    Rukmini Rajagopalan
    Roger T. Anderson
    Syam Sarma
    Carol Retchin
    John Jones
    PharmacoEconomics, 1998, 14 : 79 - 95
  • [23] Follow-up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis
    Gallo, Rosella
    Trave, Ilaria
    Castelli, Riccardo
    Gasparini, Giulia
    Parodi, Aurora
    CONTACT DERMATITIS, 2023, 89 (02) : 140 - 141
  • [24] WESSEX CARDIAC-SURGERY FOLLOW-UP SURVEY - QUALITY OF LIFE AFTER OPERATION
    ROSS, JK
    DIWELL, AE
    MARSH, J
    MONRO, JL
    BARKER, DJP
    THORAX, 1978, 33 (01) : 3 - 9
  • [25] Exploring the relationship between allergic contact dermatitis and atopic dermatitis in children: insights from a retrospective patch testing analysis
    Andre, Nicolas
    Usher, Alisa
    Ofri, Mai
    Horev, Amir
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (06) : 795 - 798
  • [26] Allergic contact dermatitis and changes in the frequency of the causative allergens demonstrated with patch testing in 2008-2012
    Tichy, Martin
    Karlova, Iva
    BIOMEDICAL PAPERS-OLOMOUC, 2015, 159 (03): : 480 - 488
  • [27] Allergic contact dermatitis in children: The Ottawa Hospital patch-testing clinic experience, 1996 to 2006
    Hogeling, Marcia
    Pratt, Melanie
    DERMATITIS, 2008, 19 (02) : 86 - 89
  • [28] Epicutaneous Patch Test Results in Children and Adults with Allergic Contact Dermatitis in Karlovac County: a Retrospective Survey
    Kuljanac, Ilko
    Knezevic, Eva
    Cvitanovic, Hrvoje
    ACTA DERMATOVENEROLOGICA CROATICA, 2011, 19 (02) : 91 - 97
  • [29] IMPROVEMENT OF QUALITY OF LIFE IN PATIENTS WITH CONCOMITANT ALLERGIC ASTHMA AND ATOPIC DERMATITIS: ONE YEAR FOLLOW-UP OF OMALIZUMAB THERAPY
    Velling, P.
    Skowasch, D.
    Pabst, S.
    Jansen, E.
    Tuleta, I.
    Grohe, C.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (09) : 407 - 410
  • [30] Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy
    P Velling
    D Skowasch
    S Pabst
    E Jansen
    I Tuleta
    C Grohé
    European Journal of Medical Research, 16